Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml
Synlett 2014; 25(4): 491-494
DOI: 10.1055/s-0033-1340598
DOI: 10.1055/s-0033-1340598
letter
Benzo[d]imidazole and Aliphatic α-Amino Acid Derived Primary Amines in Asymmetric Aldol Reactions
Further Information
Publication History
Received: 12 November 2013
Accepted after revision: 11 December 2013
Publication Date:
14 January 2014 (online)
![](https://www.thieme-connect.de/media/synlett/201404/lookinside/thumbnails/10.1055-s-0033-1340598-1.jpg)
Abstract
Starting from essential α-amino acids, four new benzo[d]imidazole and alkyl-chain-substituted primary amines were synthesized. The reaction sequence involves activation of the Boc-amino acid carboxylic acid, reaction with o-phenylenediamine, and subsequent cyclization to benzo[d]imidazole. N-Methylation and final Boc group removal afforded four new primary amines. The synthesized amines were preliminarily applied as organocatalysts in an asymmetric version of the aldol reaction between 4-nitrobenzaldehyde and acetone/cyclohexanone, achieving chemical yields of 40–64% and ee and de values up to 65 and 96%, respectively.
Key words
benzo[d]imidazole - primary amine - α-amino acid - asymmetric aldol reaction - organocatalysisSupporting Information
- for this article is available online at http://www.thieme-connect.com/ejournals/toc/synlett.
- Supporting Information
-
References and Notes
- 1 Modern Aldol Reactions . Vol. 1 and 2. Mahrwald R. Wiley-VCH; Weinheim: 2004
- 2 Enantioselective Organocatalysis: Reactions and Experimental Procedures. Dalko PI. Wiley-VCH; Weinheim: 2007
- 3a List B, Lerner RA, Barbas CF. III. J. Am. Chem. Soc. 2000; 122: 2395
- 3b List B. Tetrahedron 2002; 58: 5573
- 3c Allemann C, Gordillo R, Clemente FR, Cheong PH.-Y, Houk KN. Acc. Chem. Res. 2004; 37: 558
- 3d Notz W, Tanaka F, Barbas CF. III. Acc. Chem. Res. 2004; 37: 580
- 4a Guo Q, Zhao JC.-G. Tetrahedron Lett. 2012; 53: 1768
- 4b Hu S, Zhang L, Li J, Luo S, Cheng J.-P. Eur. J. Org. Chem. 2011; 3347
- 4c Jiang Z, Lu X. Tetrahedron Lett. 2010; 51: 1884
- 4d Zhou J, Wakchauere V, Kraft P, List B. Angew. Chem. Int. Ed. 2008; 47: 7656
- 4e Luo S, Xu H, Zhang L, Li J, Cheng J.-P. Org. Lett. 2008; 10: 653
- 4f Luo S, Xu H, Li J, Zhang L, Cheng J.-P. J. Am. Chem. Soc. 2007; 129: 3074
- 4g Peng F, Shao Z. J. Mol. Catal. A: Chem. 2008; 285: 1
- 4h Itoh S, Tokunaga T, Kurihara M, Aoki S. Tetrahedron: Asymmetry 2013; 24: 1583
- 5a Kang G, Luo Z, Liu C, Gao H, Wu Q, Wu H, Jiang J. Org. Lett. 2013; 15: 4738
- 5b Ma X, Da C.-S, Yi L, Jia Y.-N, Guo Q.-P, Che L.-P, Wu F.-C, Wang J.-R, Li W.-P. Tetrahedron: Asymmetry 2009; 20: 1419
- 5c Sakthivel K, Notz W, Bui T, Barbas CF. III. J. Am. Chem. Soc. 2001; 123: 5260
- 6a Bureš F, Kulhánek J. Tetrahedron: Asymmetry 2005; 16: 1347
- 6b Bureš F, Szotkowski T, Kulhánek J, Pytela O, Ludwig M, Holčapek M. Tetrahedron: Asymmetry 2006; 17: 900
- 6c Marek A, Kulhánek J, Ludwig M, Bureš F. Molecules 2007; 12: 1183
- 6d Sívek R, Pytela O, Bureš F. J. Heterocycl. Chem. 2008; 45: 1621
- 6e Sívek R, Bureš F, Pytela O, Kulhánek J. Molecules 2008; 13: 2326
- 6f Marek A, Kulhánek J, Bureš F. Synthesis 2010; 3188
- 7a Kwiatkowski P, Mucha P, Mlostoń G. Synlett 2009; 1757
- 7b Moore T, Merzouk M, Williams N. Synlett 2008; 21
- 7c Mazuela J, Tolstoy P, Pàmies O, Andersson PG, Diéguez M. Org. Biomol. Chem. 2011; 9: 941
- 7d Kaukoranta P, Engman M, Hedberg C, Bergquist J, Andersson PG. Adv. Synth. Catal. 2008; 350: 1168
- 7e Herrmann WA, Baskov D, Herdtweck E, Hoffmann SD, Bunlaksananusorn T, Rampf F, Rodefeld L. Organometallics 2006; 25: 2449
- 7f Zhou Y, Gong Y. Eur. J. Org. Chem. 2011; 6092
- 7g Kulhánek J, Bureš F, Šimon P, Schweizer WB. Tetrahedron: Asymmetry 2008; 19: 2462
- 7h Tydlitát J, Kulhánek J, Bureš F, Mlostoń G. Tetrahedron: Asymmetry 2012; 23: 1010
- 7i Mlostoń G, Rygielska D, Jasiński M, Heimgartner H. Tetrahedron: Asymmetry 2011; 22: 669
- 7j Mucha P, Mlostoń G, Jasiński M, Linden A, Heimgartner H. Tetrahedron: Asymmetry 2008; 19: 1600
- 7k Li Y, Ding K, Sandoval CA. Org. Lett. 2009; 11: 907
- 7l Li Y, Zhou Y, Shi Q, Ding K, Noyori R, Sandoval CA. Adv. Synth. Catal. 2011; 353: 495
- 7m Ghosh K, Sarkar T. Tetrahedron Lett. 2013; 54: 4568
- 8 Synthesis of (S)-4; Typical Procedure: Methyl chloroformate (1.6 mL, 21.2 mmol) was added to a mixture of (S)-N-Boc-ILe (4.9 g, 21.2 mmol), triethylamine (3.0 mL, 21.2 mmol), and DMF (18 mL) at –20 °C. After 15 min stirring, o-phenylenediamine (2.3 g, 21.2 mmol) was added and the reaction was stirred at 20 °C for 4 h. The solvent was evaporated and the residue was partitioned between H2O and EtOAc. The organic layer was washed with NaHCO3 (5% aq.), brine, H2O, dried (Na2SO4), and the solvent was evaporated to afford amino-amide 8 (5.7 g, 80%). A solution of 8 (5.7 g, 20.0 mmol) in glacial AcOH (10 mL) was heated at 65 °C for 1 h, then the solvent was evaporated and the residue was partitioned between H2O and EtOAc. The organic layer was washed with H2O, dried (Na2SO4), and the solvent was evaporated. Crystallization of the residue from Et2O–hexane afforded benzo[d]imidazole derivative 12 (3.9 g, 76%). Derivative 12 (1.2 g, 3.8 mmol) dissolved in anhydrous THF (20 mL) was treated with LHMDS (1 M in THF, 3.8 mL, 3.8 mmol) at 0 °C for 30 min, whereupon iodomethane (0.25 mL, 4.0 mmol) was added and the reaction was stirred at 20 °C for 3 h. The reaction was diluted with H2O and extracted with EtOAc. The organic layer was dried (Na2SO4), the solvents were evaporated, and the residue was purified by column chromatography (SiO2; EtOAc–hexane, 1:1) to gave N-methyl derivative 16 (772 mg, 64%). Boc derivative 16 (730 mg, 2.3 mmol) was treated with TFA (1 mL) at 20 °C for 1 h, then Et2O–hexane (1:1) was added to the reaction mixture until the product precipitated. The crude product was filtered and purified by column chromatography (SiO2; EtOAc–CH2Cl2–MeOH, 1:1:0.2) to afford (S)-4 (180 mg, 36%) as a viscous oil. [α]D 20 –21.8 (c 1, MeOH). 1H NMR (400 MHz, DMSO-d 6): δ = 0.85 (d, J = 6.4 Hz, 3 H, CH2CH 3), 0.90 (t, J = 7.2 Hz, CHCH 3), 1.19 and 1.75 (2 × m, 2 × 1 H, CH 2), 1.90 (m, 1 H, CH), 3.85 (s, 3 H, NCH 3), 4.03 (d, J = 7.6 Hz, 1 H, NH2CH), 7.20–7.55 (m, 2 H, CH Ar), 7.56 (d, J = 7.0 Hz, 1 H, CH Ar), 7.62 (d, J = 7.0 Hz, 1 H, CH Ar). 13C NMR (100 MHz, DMSO-d 6): δ = 11.20, 15.78, 24.06, 29.80, 39.92, 52.30, 110.02, 118.51, 121.35, 121.62, 135.68, 141.92, 157.67. MALDI-HRMS (DHB): m/z [M+H]+ calcd for C13H20N3 +: 218.1652; found: 218.1645.
- 9 Balboni G, Guerrini R, Salvadori S, Bianchi C, Rizzi D, Bryant SD, Lazarus LH. J. Med. Chem. 2002; 45: 713
- 10 Lacoste E, Landais Y, Schenk K, Verlhac J.-B, Vincent J.-M. Tetrahedron Lett. 2004; 45: 8035
- 11 Aldol Reaction; General Procedure: A solution of catalyst 1–4 (0.09 mmol) in acetone or cyclohexanone (7.5 mL) was treated with TFA (3.5 μL, 0.045 mmol) at 20 °C for 5 min, whereupon 4-nitrobenzaldehyde (151 mg, 1.0 mmol) was added and the reaction was stirred for 24 h. The solvent was evaporated and the residue was purified by column chromatography (SiO2; EtOAc–hexane, 1:1).
- 12 Enantiomeric excesses were determined by chiral phase HPLC. For 17: Daicel Chiralpak AS-H; n-hexane–i-PrOH, 70:30; flow rate 0.5 mL/min; λ = 254 nm, t R = 25.32, 33.65 min. For 18: Daicel Chiralpak AD-H; n-hexane–i-PrOH, 80:20; flow rate 0.5 mL/min; λ = 254 nm; t R = 22.69 (syn), 24.34 (syn), 26.35 (anti), 33.26 (anti) min.
For selected recent applications of chiral imidazole derivatives in asymmetric catalysis, see: